Biocryst Pharmaceuticals reported $5.11M in Stock for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adamas Pharmaceuticals ADMS:US 7.79M 252K
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 84.36M 6.68M
Chugai Pharma 4519:JP Y 199163M 14504M
Daiichi Sankyo 4568:JP Y 211808M 10948M
Gilead Sciences GILD:US $ 2988M 8M
GlaxoSmithKline GSK:LN 6330M 114M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Karyopharm Therapeutics KPTI:US $ 3.9M 791K
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Ptc Therapeutics PTCT:US $ 16.44M 0.21M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M
YTE INCY:US $ 16.68M 0.02M
Zogenix ZGNX:US $ 2.92M 0.6M